The Department of Drugs Control has advised chemists to avoid over-the-counter sale of NSAIDs such as aspirin, ibuprofen and diclofenac with immediate effect until further notice
As part of de-risking their business, they have started reducing the share of ibuprofen in their overall turnover, and add more popular products to the portfolio
